Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms
<p>Supplementary Table 1</p>
সংরক্ষণ করুন:
| প্রধান লেখক: | |
|---|---|
| অন্যান্য লেখক: | , , , , , , , , , , , , , , , |
| প্রকাশিত: |
2025
|
| বিষয়গুলি: | |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| _version_ | 1849927633366679552 |
|---|---|
| author | Lindsay M. Gurska (15056629) |
| author2 | Rachel Okabe (15056632) Alexandra Schurer (15056635) Meng Maxine Tong (15056638) Mark Soto (15056641) Daniel Choi (15056644) Kristina Ames (15056647) Shira Glushakow-Smith (15056650) Allison Montoya (15056653) Ellen Tein (15056656) Linde A. Miles (15056659) Haiying Cheng (15056662) Pamela Hankey-Giblin (15056665) Ross L. Levine (15056668) Swati Goel (15056671) Balazs Halmos (15056674) Kira Gritsman (15051360) |
| author2_role | author author author author author author author author author author author author author author author author |
| author_facet | Lindsay M. Gurska (15056629) Rachel Okabe (15056632) Alexandra Schurer (15056635) Meng Maxine Tong (15056638) Mark Soto (15056641) Daniel Choi (15056644) Kristina Ames (15056647) Shira Glushakow-Smith (15056650) Allison Montoya (15056653) Ellen Tein (15056656) Linde A. Miles (15056659) Haiying Cheng (15056662) Pamela Hankey-Giblin (15056665) Ross L. Levine (15056668) Swati Goel (15056671) Balazs Halmos (15056674) Kira Gritsman (15051360) |
| author_role | author |
| dc.creator.none.fl_str_mv | Lindsay M. Gurska (15056629) Rachel Okabe (15056632) Alexandra Schurer (15056635) Meng Maxine Tong (15056638) Mark Soto (15056641) Daniel Choi (15056644) Kristina Ames (15056647) Shira Glushakow-Smith (15056650) Allison Montoya (15056653) Ellen Tein (15056656) Linde A. Miles (15056659) Haiying Cheng (15056662) Pamela Hankey-Giblin (15056665) Ross L. Levine (15056668) Swati Goel (15056671) Balazs Halmos (15056674) Kira Gritsman (15051360) |
| dc.date.none.fl_str_mv | 2025-11-25T13:04:48Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707212 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_1_from_Crizotinib_Has_Preclinical_Efficacy_in_Philadelphia-Negative_Myeloproliferative_Neoplasms/30707212 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling Receptors Hematological Cancers Small Molecule Agents Kinase inhibitors Translational Research |
| dc.title.none.fl_str_mv | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Supplementary Table 1</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_37037d971fdf2468e1da96f6e2af75d6 |
| identifier_str_mv | 10.1158/1078-0432.30707212 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707212 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative NeoplasmsLindsay M. Gurska (15056629)Rachel Okabe (15056632)Alexandra Schurer (15056635)Meng Maxine Tong (15056638)Mark Soto (15056641)Daniel Choi (15056644)Kristina Ames (15056647)Shira Glushakow-Smith (15056650)Allison Montoya (15056653)Ellen Tein (15056656)Linde A. Miles (15056659)Haiying Cheng (15056662)Pamela Hankey-Giblin (15056665)Ross L. Levine (15056668)Swati Goel (15056671)Balazs Halmos (15056674)Kira Gritsman (15051360)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentCell SignalingReceptorsHematological CancersSmall Molecule AgentsKinase inhibitorsTranslational Research<p>Supplementary Table 1</p>2025-11-25T13:04:48ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30707212https://figshare.com/articles/dataset/Supplementary_Table_1_from_Crizotinib_Has_Preclinical_Efficacy_in_Philadelphia-Negative_Myeloproliferative_Neoplasms/30707212CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307072122025-11-25T13:04:48Z |
| spellingShingle | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms Lindsay M. Gurska (15056629) Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling Receptors Hematological Cancers Small Molecule Agents Kinase inhibitors Translational Research |
| status_str | publishedVersion |
| title | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| title_full | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| title_fullStr | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| title_full_unstemmed | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| title_short | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| title_sort | Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms |
| topic | Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling Receptors Hematological Cancers Small Molecule Agents Kinase inhibitors Translational Research |